Indium phosphide
Indium phosphide is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties

Indium phosphide
Indium phosphide is a phosphide of indium. It is a semiconductor used in high-power and high-frequency electronics because of its superior electron velocity with respect to the more common semiconductors silicon and gallium arsenide. It also has a direct bandgap, making it useful for optoelectronics devices like laser diodes. Metal phosphides are hydrolysed to phosphine upon contact with water or stomach acid. Phosphine is a colorless, flammable, explosive, and toxic gas. (L980, L986) — Toxin and Toxin Target Database (T3DB)
- IUPAC name
- indiganylidynephosphane
- Molecular formula
- InP
- Molecular weight
- 145.792 g/mol
- Exact mass
- 145.8776408 Da
- Topological polar surface area
- 0.0 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 0
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
13 more reported names
External database identifiers
- EPA DTXSID:DTXSID3031444
- PubMed:25527823
- PubMed:11921183
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Indium phosphide
Chemical / IUPAC name
Indium phosphide
Regulatory information
CMR
| Category | Carcinogenic | Mutagenic | Reprotoxic |
|---|---|---|---|
| Cat. 1B | ✓ | — | — |
| Cat. 2 | — | — | ✓ |
Key data
Related records for Indium phosphide
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
Tris[2-chloro-1-(chloromethyl)ethyl] phosphate
Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or othe…
Hexabromocyclododecane [1]; 1,2,5,6,9,10-Hexabromocyclododecane [2]
Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or othe…
Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or othe…
Abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]; Avermectin B1a [2]
Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or othe…
Reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)…
Leucomalachite green; N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline
What Annex II means for Indium phosphide
Indium phosphide is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
- This substance has CMR classification. Review the CMR table above and verify current Annex II/III status before use.
Frequently asked questions
Source note for Annex II record Indium phosphide
This page summarizes one Annex II record for Indium phosphide from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Indium phosphide, but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Indium phosphide and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Indium phosphide side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II